EXEL: 伊克力西斯

EXEL新闻

• 23:07 No. 1 Rated Drugmaker Lilly Hits Record High, Leads 18 Onto Best Growth Stock Lists
• 15:30 Exelixis (EXEL) Up 6% Since Last Earnings Report: Can It Continue?
• 13:45 Why Exelixis (EXEL) is a Top Growth Stock for the Long-Term
• 13:40 Why Exelixis (EXEL) is a Top Value Stock for the Long-Term
• 13:50 Why Exelixis (EXEL) is a Top Momentum Stock for the Long-Term
• 20:48 Dow Jones Futures: Stock Market Hits Highs On U.S.-Iran Deal; Dell Surges On Earnings
• 07:00 Exelixis, Inc. (EXEL) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
• 21:26 Exelixis: Financial Performance Improves Faster Than Market Expectations (NASDAQ:EXEL)
• 00:21 Tracking Renaissance Technologies (RenTec) 13F Portfolio – Q1 2026 Update
• 20:00 Exelixis, Inc. (EXEL) Presents at Stifel 2026 Targeted Oncology Virtual Forum Transcript
• 18:35 EXEL Collaborates With MRK for Late-Stage Colorectal Cancer Study
• 15:00 Exelixis, Inc. (EXEL) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
• 13:50 Exelixis (EXEL) is a Top-Ranked Momentum Stock: Should You Buy?
• 16:19 Stock Market Soars On Tumbling Oil Prices, Strong Earnings: Weekly Review
• 15:59 EXEL Q1 Earnings Top Estimates, Colorectal Cancer Drug in Focus
• 13:40 Here's Why Exelixis (EXEL) is a Strong Value Stock
• 07:31 Exelixis, Inc. (EXEL) Q1 2026 Earnings Call Transcript
• 21:30 Exelixis (EXEL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
• 21:15 Exelixis (EXEL) Tops Q1 Earnings Estimates
• 13:45 Here's Why Exelixis (EXEL) is a Strong Growth Stock
• 14:00 Exelixis (EXEL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
• 00:16 Recursion Pharmaceuticals May Be Losing Ground To Its Peers (NASDAQ:RXRX)
• 23:03 AI Chip Gear Maker Lam Research Leads 13 Stocks Onto These Top IBD Screens
• 13:40 Why Exelixis (EXEL) is a Top Value Stock for the Long-Term